ALEXION PHARMACEUTICALS INC.

In News

Alexion Pharmaceuticals Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs

Revelio Labs - Jul 29, 2026

Genentech, two other drug companies object to Lilly's planned buyout of bankrupt Sangamo's tech - The Business Journals

The Business Journals - Aug 18, 2026

Xencor to Receive $105 Million From Alexion to Resolve Ultomiris® U.S. Royalty Matter - Yahoo Finance

Yahoo Finance - Jul 29, 2026

AstraZeneca highlights rare diseases in $80bn revenue push - Financial Times

Financial Times - Jul 19, 2026

Alexion Beats Trade Secret Claims In Amyndas Suit - Law360

Law360 - Apr 02, 2026

AstraZeneca's Ultomiris wins US FDA priority review in kidney disease - Morningstar

Morningstar - Jun 15, 2026

Massachusetts Federal Court Reinforces Chapter 93A Causation Requirement and Rejects Trade Secret Misuse Theory in Pharmaceutical Case - The National Law Review

The National Law Review - Jun 02, 2026

Ex-employees get jury trial on ‘age-biased’ rehiring program - Massachusetts Lawyers Weekly

Massachusetts Lawyers Weekly - Apr 07, 2026

Koselugo approved in the US for adults with neurofibromatosis type 1 - AstraZeneca

AstraZeneca - Nov 20, 2025

Chancery Sets Hybrid Interest Formula In Alexion Merger Fight - Law360

Law360 - Aug 05, 2026

Royalty Rift: Alexion Cuts Off US Royalty Payments To Xencor - Bitget

Bitget - Mar 05, 2026

Geographic Atrophy Market to Surge Significantly During the - GlobeNewswire

GlobeNewswire - Dec 01, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment